Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.
Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V.
Höglander EK, et al. Among authors: wist e.
Genome Med. 2018 Nov 29;10(1):92. doi: 10.1186/s13073-018-0601-y.
Genome Med. 2018.
PMID: 30497530
Free PMC article.
Clinical Trial.